Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study : comment
| Errataetall: |
CommentOn: Intern Emerg Med. 2021 Jun;16(4):843-852. - PMID 33400157 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Internal and emergency medicine - 16(2021), 4 vom: 17. Juni, Seite 1101-1103 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yurttutan, Sadık [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 17.06.2021 Date Revised 07.12.2022 published: Print-Electronic CommentOn: Intern Emerg Med. 2021 Jun;16(4):843-852. - PMID 33400157 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11739-021-02663-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321577213 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321577213 | ||
| 003 | DE-627 | ||
| 005 | 20231225180116.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11739-021-02663-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1071.xml |
| 035 | |a (DE-627)NLM321577213 | ||
| 035 | |a (NLM)33598871 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yurttutan, Sadık |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study |b comment |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.06.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Intern Emerg Med. 2021 Jun;16(4):843-852. - PMID 33400157 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Interleukin 1 Receptor Antagonist Protein |2 NLM | |
| 650 | 7 | |a tocilizumab |2 NLM | |
| 650 | 7 | |a I031V2H011 |2 NLM | |
| 700 | 1 | |a Gullu, Utku Ufuk |e verfasserin |4 aut | |
| 700 | 1 | |a Ipek, Sevcan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal and emergency medicine |d 2006 |g 16(2021), 4 vom: 17. Juni, Seite 1101-1103 |w (DE-627)NLM165086432 |x 1828-0447 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g number:4 |g day:17 |g month:06 |g pages:1101-1103 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11739-021-02663-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2021 |e 4 |b 17 |c 06 |h 1101-1103 | ||